These data confirm that at least some Mo that differentiate into Mo-Mφ acquire a pro-tumoral phenotype, but also show that KCs are part of the TAM population and enhance tumor progression [17, 58, 72–74], although they were initially thought to be only involved in anti-tumor immunity. The gene discussed is TBCE; the disease is neoplasm.